Search Result

Results for "

miR-29b

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Apoptosis (1) MicroRNA (22)
By Research Areas:	Cancer (21) Inflammation/Immunology (2)
Oligonucleotides:	miRNA mimics (5) miRNA agomirs (5) miRNA antagomirs (5) MicroRNAs (22) miRNA inhibitors (5)

Inhibitors & Agonists

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-132602

Remlarsen MRG-201	MicroRNA	Inflammation/Immunology
Remlarsen (MRG-201), a miR-29b mimic, acts a *miR-29b* agonist. Remlarsen has the potential for preventiong formation of a fibrotic scar or cutaneous fibrosis .

HY-132602A

Remlarsen sodium MRG-201 sodium	MicroRNA	Inflammation/Immunology
Remlarsen (MRG-201), a miR-29b mimic, acts a *miR-29b* agonist. Remlarsen sodium has the potential for preventiong formation of a fibrotic scar or cutaneous fibrosis .

HY-19542

C6 Ceramide 2 Publications Verification C6-Cer; N-Hexanoylsphingosine	Apoptosis	Cancer
C6 Ceramide (C6-Cer) is a short-chain, cell-permeable ceramide pathway activator with anticancer activity. C6 Ceramide-mediated miR-29b expression participates in the progression of multiple myeloma through suppressing the proliferation, migration and angiogenesis of endothelial cells by targeting Akt signal pathway. C6 Ceramide exhibits multiple anti-cancer properties including cell cycle arrest, Apoptosis, inhibition of tumor growth and enhances the effects of chemotherapy in drug-resistant cancer cells. C6-ceramide can be used as an adjuvant for chemotherapeutic agents, to enhance anti-tumor effects .

HY-R00512

*hsa-miR-29b-1-5p mimic*	MicroRNA	Cancer
hsa-miR-29b-1-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-29b-1-5p mimic hsa-miR-29b-1-5p mimic

HY-R00513

*hsa-miR-29b-2-5p mimic*	MicroRNA	Cancer
hsa-miR-29b-2-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-29b-2-5p mimic hsa-miR-29b-2-5p mimic

HY-R02889

*mmu-miR-29b-1-5p mimic*	MicroRNA	Cancer
mmu-miR-29b-1-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-29b-1-5p mimic mmu-miR-29b-1-5p mimic

HY-R02890

*mmu-miR-29b-2-5p mimic*	MicroRNA	Cancer
mmu-miR-29b-2-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-29b-2-5p mimic mmu-miR-29b-2-5p mimic

HY-R04332

*rno-miR-29b-1-5p mimic*	MicroRNA	Cancer
rno-miR-29b-1-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

rno-miR-29b-1-5p mimic rno-miR-29b-1-5p mimic

HY-RI00512

*hsa-miR-29b-1-5p inhibitor*	MicroRNA	Cancer
hsa-miR-29b-1-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-29b-1-5p inhibitor hsa-miR-29b-1-5p inhibitor

HY-RI00513

*hsa-miR-29b-2-5p inhibitor*	MicroRNA	Cancer
hsa-miR-29b-2-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-29b-2-5p inhibitor hsa-miR-29b-2-5p inhibitor

HY-RI02889

*mmu-miR-29b-1-5p inhibitor*	MicroRNA	Cancer
mmu-miR-29b-1-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-29b-1-5p inhibitor mmu-miR-29b-1-5p inhibitor

HY-RI02890

*mmu-miR-29b-2-5p inhibitor*	MicroRNA	Cancer
mmu-miR-29b-2-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-29b-2-5p inhibitor mmu-miR-29b-2-5p inhibitor

HY-RI04332

*rno-miR-29b-1-5p inhibitor*	MicroRNA	Cancer
rno-miR-29b-1-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-29b-1-5p inhibitor rno-miR-29b-1-5p inhibitor

HY-R00512A

*hsa-miR-29b-1-5p agomir*	MicroRNA	Cancer
hsa-miR-29b-1-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-29b-1-5p agomir hsa-miR-29b-1-5p agomir

HY-R00513A

*hsa-miR-29b-2-5p agomir*	MicroRNA	Cancer
hsa-miR-29b-2-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-29b-2-5p agomir hsa-miR-29b-2-5p agomir

HY-R02889A

*mmu-miR-29b-1-5p agomir*	MicroRNA	Cancer
mmu-miR-29b-1-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-29b-1-5p agomir mmu-miR-29b-1-5p agomir

HY-R02890A

*mmu-miR-29b-2-5p agomir*	MicroRNA	Cancer
mmu-miR-29b-2-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-29b-2-5p agomir mmu-miR-29b-2-5p agomir

HY-R04332A

*rno-miR-29b-1-5p agomir*	MicroRNA	Cancer
rno-miR-29b-1-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-29b-1-5p agomir rno-miR-29b-1-5p agomir

HY-RI00512A

*hsa-miR-29b-1-5p antagomir*	MicroRNA	Cancer
hsa-miR-29b-1-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-29b-1-5p antagomir hsa-miR-29b-1-5p antagomir

HY-RI00513A

*hsa-miR-29b-2-5p antagomir*	MicroRNA	Cancer
hsa-miR-29b-2-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-29b-2-5p antagomir hsa-miR-29b-2-5p antagomir

HY-RI02889A

*mmu-miR-29b-1-5p antagomir*	MicroRNA	Cancer
mmu-miR-29b-1-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-29b-1-5p antagomir mmu-miR-29b-1-5p antagomir

HY-RI02890A

*mmu-miR-29b-2-5p antagomir*	MicroRNA	Cancer
mmu-miR-29b-2-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-29b-2-5p antagomir mmu-miR-29b-2-5p antagomir

HY-RI04332A

*rno-miR-29b-1-5p antagomir*	MicroRNA	Cancer
rno-miR-29b-1-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-29b-1-5p antagomir rno-miR-29b-1-5p antagomir

Cat. No.	Product Name		Classification